CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-18 | Rivera Jose E EVP, General Counsel | Option exercise | +10,000 | $6.83 | $68K | 37,524 |
| 2020-08-18 | Rivera Jose E EVP, General Counsel | Sale | −5,615 | $21.00 | $118K | 31,909 |
| 2020-08-18 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −10,000 | 135,117 | ||
| 2020-08-06 | LEONARD JOHN M. President and CEO | Option exercise | +5,000 | $6.83 | $34K | 472,352 |
| 2020-08-06 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-08-06 | LEONARD JOHN M. President and CEO | Option exercise · Stock Option (right to buy) | −5,000 | 335,234 | ||
| 2020-07-15 | Rivera Jose E EVP, General Counsel | Option exercise | +10,000 | $6.83 | $68K | 33,139 |
| 2020-07-15 | Rivera Jose E EVP, General Counsel | Sale | −5,615 | $22.70 | $127K | 27,524 |
| 2020-07-15 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −10,000 | 145,117 | ||
| 2020-07-01 | LEONARD JOHN M. President and CEO | Option exercise | +5,000 | $6.83 | $34K | 472,352 |
| 2020-07-01 | LEONARD JOHN M. President and CEO | Sale | −5,000 | $21.83 | $109K | 467,352 |
| 2020-07-01 | LEONARD JOHN M. President and CEO | Option exercise · Stock Option (right to buy) | −5,000 | 340,234 | ||
| 2020-06-18 | Cohen Fred E Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-18 | Verwiel Frank Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-18 | KARSEN PERRY A Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-18 | GOODMAN JESSE Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-18 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-18 | DORSA CAROLINE Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2020-06-16 | Rivera Jose E EVP, General Counsel | Option exercise | +10,000 | $6.83 | $68K | 27,897 |
| 2020-06-16 | Rivera Jose E EVP, General Counsel | Sale | −5,615 | $21.00 | $118K | 22,282 |
Page 32 of 40 · 783 trades